The nasal epithelium as a factory for systemic protein delivery
- PMID: 11829516
- DOI: 10.1006/mthe.2002.0524
The nasal epithelium as a factory for systemic protein delivery
Abstract
We have previously shown that recombinant Sendai virus (SeV) produces efficient in vivo airway epithelial gene transfer. The ability to produce therapeutic levels of circulating proteins following noninvasive gene transfer would have widespread clinical application. Here, we compared nose, lung, and skeletal muscle for the ability to produce circulating levels of the secreted mouse antiinflammatory cytokine interleukin-10 (IL10) following SeV-mediated gene transfer. High levels of serum IL10 were obtained from each site with a potency order of lung > nose > muscle for a given viral titer. Serum levels from each site were within the likely required range for anti-inflammatory effects. The combination of a high-efficiency gene transfer agent (SeV) and sites that can be assessed noninvasively (nose or lung) may circumvent several current challenges to gene therapy.
Similar articles
-
Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice.Gene Ther. 2003 Feb;10(3):213-8. doi: 10.1038/sj.gt.3301847. Gene Ther. 2003. PMID: 12571628
-
Efficient gene transfer to airway epithelium using recombinant Sendai virus.Nat Biotechnol. 2000 Sep;18(9):970-3. doi: 10.1038/79463. Nat Biotechnol. 2000. PMID: 10973218
-
A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.Gene Ther. 2004 Nov;11(22):1659-64. doi: 10.1038/sj.gt.3302334. Gene Ther. 2004. PMID: 15284837
-
Sendai virus for gene therapy and vaccination.Curr Opin Mol Ther. 2005 Aug;7(4):346-52. Curr Opin Mol Ther. 2005. PMID: 16121700 Review.
-
Sendai virus vectors as an emerging negative-strand RNA viral vector system.J Gene Med. 2003 Jul;5(7):543-53. doi: 10.1002/jgm.426. J Gene Med. 2003. PMID: 12825193 Review.
Cited by
-
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.Am J Respir Crit Care Med. 2012 Nov 1;186(9):846-56. doi: 10.1164/rccm.201206-1056OC. Epub 2012 Sep 6. Am J Respir Crit Care Med. 2012. PMID: 22955314 Free PMC article.
-
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins.Gene Ther. 2018 Aug;25(5):345-358. doi: 10.1038/s41434-018-0025-8. Epub 2018 Jul 18. Gene Ther. 2018. PMID: 30022127 Free PMC article.
-
The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways.Biomaterials. 2010 Mar;31(9):2665-72. doi: 10.1016/j.biomaterials.2009.12.005. Epub 2009 Dec 21. Biomaterials. 2010. PMID: 20022367 Free PMC article.
-
Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets.Mol Ther Nucleic Acids. 2019 Jun 7;16:186-193. doi: 10.1016/j.omtn.2019.02.016. Epub 2019 Feb 26. Mol Ther Nucleic Acids. 2019. PMID: 30897407 Free PMC article.
-
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression.Mol Ther Methods Clin Dev. 2022 Apr 14;25:382-391. doi: 10.1016/j.omtm.2022.04.002. eCollection 2022 Jun 9. Mol Ther Methods Clin Dev. 2022. PMID: 35573048 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources